REEV’s Neuro-Integration Program Doubles in Four Months

Jefferson Moss-Magee Rehabilitation, Community Health System, and DHR Health join REEV’s NIP, extending the program’s reach to the West Coast and South Texas.

BOSTON, MA, UNITED STATES, September 15, 2026 /EINPresswire.com/ — Four months after announcing its founding clinical partners, REEV’s Neuro-Integration Program (NIP) doubled in size, bringing the total number of signed clinical partners to six and counting.

The NIP is a clinical collaboration initiative with leading stroke rehabilitation organizations to prepare for the future commercial introduction of DREEVEN, REEV’s AI-powered robotic knee orthosis. DREEVEN is designed to help stroke survivors regain safe, independent mobility for daily life.

Jefferson Moss-Magee Rehabilitation, a U.S. News & World Report top 10 rehabilitation facility, joins, led by Dr. Alberto Esquenazi, MD, Department Chair and Chief Clinical Officer. Community Health System, a regional health system in California’s Central Valley, joins with Julie Evans, OTR/L, CHT, Manager, Outpatient Rehabilitation, leading the program. DHR Health in South Texas joins with Michael Auer, PT, DPT, C/NDT, Director of the Neuro Therapy Institute and Cardiac Rehabilitation, overseeing the NIP.

“It’s exciting to be a founding clinical collaboration partner with REEV’s Neuro-Integration Program and also the only health system on the West Coast,” said Julie Evans, OTR/L, CHT, Community’s Outpatient Rehabilitation manager. “Community always looks for ways our patients will benefit from innovation and technology and this could directly impact our patients with gait rehabilitation, helping stroke survivors regain safe, independent mobility for daily life.”

Here’s what Michael E. Auer, PT, DPT, C/NDT shared about REEV and the Neuro-Integration Program:

“At DHR Health, we are committed to seeking out innovative, evidence-based therapies that give our patients access to the very best care and the greatest opportunities for recovery. Utilizing REEV SENSE allows us to analyze patients’ walking patterns so we can tailor the best treatment strategies that yield the best outcomes. We look forward to using DREEVEN, REEV’s AI-powered robotic knee orthosis. We now have another innovative tool that can help us provide targeted gait training for stroke survivors and support their journey toward safer, more independent mobility.”

NIP partner facilities collectively serve approximately 1,000 stroke patients who are expected to be potential candidates for DREEVEN at launch. More than 2,000 patients have been assessed through SENSE, REEV’s gait analysis system, which helps clinicians identify potential DREEVEN candidates and contribute to one of the largest real-world datasets focused on gait rehabilitation that should help support reimbursement workflows.

REEV’s CEO and Co-Founder, Amaury Ciurana says, “This growth reflects the strong momentum of the Neuro-Integration Program and a real demand for better options for stroke survivors. Too many people who survive a stroke struggle with limited mobility and the isolation and inactivity that come with it. We believe DREEVEN can be a critical piece in restoring daily mobility.”

REEV is in active discussions with 25 major hospital systems, representing more than 5,000 stroke survivors who may benefit from DREEVEN across 20 U.S. states. The expansion of the Neuro-Integration Program reflects REEV’s commitment to building the clinical foundation that bringing a new class of technology to stroke patients responsibly requires. The NIP partnerships ensure the infrastructure and evidence are in place, and the right patients are ready when DREEVEN becomes available.

DREEVEN is an investigational device that has not been cleared or approved for commercial sale in the United States.

About REEV

REEV is a medical technology company with offices in Toulouse, France, and Boston, Massachusetts. Its mission is to reinvent mobility care for millions of people facing physical limitations due to aging, neurological conditions, or orthopedic disorders through intelligent, lightweight wearable robotics. REEV’s technology portfolio includes REEV SENSE, a HIPAA-compliant, FDA-cleared gait analysis system, and DREEVEN, a prescription-based, intelligent robotic knee brace, currently in clinical trials.

Megan Hoogmoed
REEV
+1 857-277-3573
megan.hoogmoed@reev.care
Visit us on social media:
LinkedIn
Other

Media gallery